Bank of New York Mellon’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $942K | Buy |
+185,894
| New | +$942K | ﹤0.01% | 3143 |
|
|
2024
Q1 | – | Sell |
-16,426
| Closed | -$23.2K | – | 4316 |
|
|
2023
Q4 | $23.2K | Hold |
16,426
| – | – | ﹤0.01% | 4221 |
|
|
2023
Q3 | $26K | Hold |
16,426
| – | – | ﹤0.01% | 4216 |
|
|
2023
Q2 | $35.5K | Sell |
16,426
-19,442
| -54% | -$42K | ﹤0.01% | 4213 |
|
|
2023
Q1 | $75.3K | Buy |
+35,868
| New | +$75.3K | ﹤0.01% | 4117 |
|
|
2018
Q2 | – | Sell |
-1,824
| Closed | -$68K | – | 4306 |
|
|
2018
Q1 | $68K | Sell |
1,824
-74
| -4% | -$2.76K | ﹤0.01% | 4110 |
|
|
2017
Q4 | $93K | Sell |
1,898
-46
| -2% | -$2.25K | ﹤0.01% | 4096 |
|
|
2017
Q3 | $137K | Hold |
1,944
| – | – | ﹤0.01% | 3945 |
|
|
2017
Q2 | $93K | Sell |
1,944
-17
| -0.9% | -$813 | ﹤0.01% | 4041 |
|
|
2017
Q1 | $96K | Hold |
1,961
| – | – | ﹤0.01% | 4033 |
|
|
2016
Q4 | $59K | Buy |
1,961
+568
| +41% | +$17.1K | ﹤0.01% | 4109 |
|
|
2016
Q3 | $62K | Buy |
+1,393
| New | +$62K | ﹤0.01% | 4108 |
|
|
2016
Q2 | – | Sell |
-2,591
| Closed | -$143K | – | 4353 |
|
|
2016
Q1 | $143K | Buy |
2,591
+1,103
| +74% | +$60.9K | ﹤0.01% | 3883 |
|
|
2015
Q4 | $205K | Hold |
1,488
| – | – | ﹤0.01% | 3839 |
|
|
2015
Q3 | $214K | Sell |
1,488
-64
| -4% | -$9.2K | ﹤0.01% | 3841 |
|
|
2015
Q2 | $402K | Buy |
+1,552
| New | +$402K | ﹤0.01% | 3710 |
|